Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of TDF and Entekavir Prophylaxis at Hepatitis B Reactivation: Multi Center Retrospective Study

NCT06049602 is registered in ClinicalTrials.gov with Viral Hepatitis Society as lead sponsor.

NCT NCT06049602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06049602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of TDF and Entekavir Prophylaxis at Hepatitis B Reactivation: Multi Center Retrospective Study
Lead sponsor
Viral Hepatitis Society
Phase
Observational
Overall status
Unknown status
Start date
January 15, 2023
Completion date
December 31, 2023
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b reactivation